share_log

荣昌生物(09995):作废部分2022年A股限制性股票激励计划已授予尚未归属的限制性股票

REMEGEN (09995): The invalidation of some unvested restricted stocks granted under the 2022 A-share restricted stock incentive plan.

Zhitong Finance ·  Dec 30, 2024 07:25

REMEGEN (09995) released an announcement based on the "Management Measures for Stock-based Incentive of Listed Companies" and "2022 A-shares Limitation..."

According to the announcement from REMEGEN (09995) and in accordance with the "Management Measures for Listed Company Stock-based Incentive" and the relevant regulations of the "2022 A-share Restricted Stock Incentive Plan" and its summary, due to the fact that 4 recipients of Class A rights and 35 recipients of Class B rights have lost their eligibility for incentives due to resignation, and 1 incentive recipient has voluntarily waived their vested rights, the restricted stocks that were granted but have not yet vested will not be vested. A total of 0.38924 million shares of restricted stocks will be invalidated by the company.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment